In addition, fexofenadine, an antihistamine agent for allergic rhinitis and urticaria (148), has been found to prevent DSS-induced colitis by blocking ER stress-induced eIF2α and inhibiting NF-κB signaling in IECs through a histone receptor-independent signaling (149). This evidence concerns the gene EIF2A and colitis.